Where does the UK market stand in global pharma?
Is pharma entering a new age of innovation and productivity, and where does the UK stand in the global market? The strength of global pharma...
Changes to pharma and healthcare in 2019
Continuing funding shortages, Brexit uncertainty, regulator moves and regulation reforms: there is no shortage of change facing the sector in 2019. We asked the industry’s...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
An insight to the changing healthcare landscape and technological innovations
Declan Cassells is Managing Director of Renew Health. He shares his insights on the changing healthcare landscape, technological innovations and connected health. What do you...
Use of bio-feedback for bowel management
Bowel management – how to help: Biofeedback may be helpful if first line measures have not worked There are two broad categories of bowel symptoms,...
Beyond pharma: The role of medtech in antimicrobial resistance
Paul Chapman, Chartered (UK) and European Patent Attorney, discusses the role of medtech in antimicrobial resistance. A major review published by the World Health Organisation...
Understanding men’s health: Men’s health matters
Why do men find it hard to get help for their health worries? Pf Magazine explores understanding men's health. Whether it’s because they’re embarrassed, don’t...
A year in pharma
It’s hard to believe, but as quick as a flash it’s December – which seems a fitting time to reflect on a year in...
Remembering 2018: Changes to the pharmaceutical industry in 2018
In the unlikely event of an orderly Brexit occurring with barely a ripple of disruption to the financial sector, agriculture industry, world of academia,...
Therapy areas of the future
Research into medical treatments has never been more exciting. From personalised medicine and gene editing to immunotherapy, we look at where the next breakthroughs...
Latest articles
Janssen’s prostate cancer treatment Erleada receives EC licence
Johnson & Johnson announce that the European Commission (EC) has licensed prostate cancer treatment Erleada for non-metastatic castration-resistant prostate cancer (nmCRPC) The licence is based on...
The role of the cloud in transforming engagement for precision medicine
What role does technology play in transforming engagement to deliver precision information for precision medicine? Malia Lewin explores. Oncology is both the largest and fastest-growing therapeutic...
NICE: Procedure could make more livers viable for transplant
A procedure assessed by NICE has been hailed as an “exciting development” in increasing the number of livers viable for transplant. A perfusion machine can...